Webinar | September 22, 2021

Recombinant Antibody Technology: Versatile Platforms For Diverse Engineering And Custom Services

Source: bio-techne

Antibodies play a critical role in research, diagnostics and therapeutics. Recombinant antibodies offer a wide range of quality attributes, with one key advantage being their amenability to sequence-based editing to meet specific research goals.

At Bio-Techne, we have developed and optimized a powerful and highly versatile technology platform for custom recombinant antibody development and engineering applications. Utilising a modular approach, recombinant antibodies can be rapidly engineered into diverse formats (e.g. ScFv, F(ab) or F(ab')2 truncations), and novel molecules such as immunocytokines or bispecific antibodies.

Join this on-demand webinar to learn about the latest developments in recombinant antibody technology. Find out from our experts how specific client research challenges were successfully solved, from cell and gene therapy, immunotherapy to antibody manufacturability.

VIEW THE WEBINAR!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: